[1]
Altomare, BS, C., Kinzler, PhD, E.R., Buchhalter, PhD, A.R., Cone, PhD, E.J. and Costantino, PhD, A. 2017. Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration’s recommendation for Category 1 Testing. Journal of Opioid Management. 13, 6 (Dec. 2017), 441–448. DOI:https://doi.org/10.5055/jom.2017.0420.